Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,232.00    -30.00 (-2.38%)
Bid:
1,232.00
Ask:
1,246.00
Spread: 14.00 (1.136%)
Market Cap: £239.12m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Holding(s) in Company

7 May 2025 13:36

The Biotech Growth Trust PLC - Holding(s) in Company

The Biotech Growth Trust PLC - Holding(s) in Company

PR Newswire

LONDON, United Kingdom, May 07

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0000385517

Issuer Name

THE BIOTECH GROWTH TRUST PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

 City of Bradford - West Yorkshire Pension Fund

City of registered office (if applicable)

BRADFORD

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

02-Mary-2025

6. Date on which Issuer notified

07-May-2025

7. Total positions of person(s) subject to the notification obligation

.

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.020000

0.000000

4.020000

1070689

Position of previous notification (if applicable)

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0000385517

 

1070689

 

4.020000

Sub Total 8.A

1070689

4.020000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

07-May-2025

13. Place Of Completion

BRADFORD



Date   Source Headline
29th Dec 20251:56 pmPRNNet Asset Value(s)
24th Dec 202511:38 amPRNNet Asset Value(s)
23rd Dec 20255:13 pmRNSTransaction in Own Shares
23rd Dec 20255:13 pmPRNTransaction in Own Shares
23rd Dec 202512:07 pmPRNNet Asset Value(s)
22nd Dec 202512:55 pmRNSBioMarin Pharmaceuticals to acquire BIOG portfolio company, Amicus Therapeutics
22nd Dec 202512:55 pmPRNBioMarin Pharmaceuticals to acquire BIOG portfolio company, Amicus Therapeutics
22nd Dec 202512:26 pmPRNNet Asset Value(s)
19th Dec 20255:27 pmRNSTransaction in Own Shares
19th Dec 20255:27 pmPRNTransaction in Own Shares
19th Dec 20251:46 pmPRNNet Asset Value(s)
18th Dec 20254:00 pmPRNNet Asset Value(s)
17th Dec 20252:00 pmPRNNet Asset Value(s)
16th Dec 202512:41 pmPRNNet Asset Value(s)
15th Dec 20251:59 pmPRNNet Asset Value(s)
12th Dec 20255:33 pmPRNTransaction in Own Shares
12th Dec 20252:24 pmPRNMonthly Fact Sheet as at 30 November 2025
12th Dec 20252:20 pmPRNNet Asset Value(s)
11th Dec 20251:58 pmPRNNet Asset Value(s)
10th Dec 202512:56 pmPRNNet Asset Value(s)
9th Dec 20251:21 pmPRNNet Asset Value(s)
8th Dec 20251:24 pmPRNNet Asset Value(s)
5th Dec 20255:18 pmPRNTransaction in Own Shares
5th Dec 20252:24 pmPRNNet Asset Value(s)
4th Dec 20251:28 pmPRNNet Asset Value(s)
3rd Dec 20253:46 pmPRNNet Asset Value(s)
2nd Dec 20253:31 pmPRNDirector Declaration
2nd Dec 20251:24 pmPRNNet Asset Value(s)
1st Dec 20252:36 pmPRNNet Asset Value(s)
1st Dec 20259:47 amPRNTotal Voting Rights
28th Nov 20255:17 pmPRNTransaction in Own Shares
28th Nov 20251:11 pmPRNNet Asset Value(s)
27th Nov 20251:34 pmPRNNet Asset Value(s)
26th Nov 20253:23 pmPRNNet Asset Value(s)
25th Nov 20251:03 pmPRNNet Asset Value(s)
24th Nov 20251:16 pmPRNNet Asset Value(s)
21st Nov 20255:07 pmPRNTransaction in Own Shares
21st Nov 202512:27 pmPRNNet Asset Value(s)
20th Nov 20251:07 pmPRNNet Asset Value(s)
20th Nov 20257:00 amPRNHalf-year Financial Report
19th Nov 20251:55 pmPRNNet Asset Value(s)
18th Nov 20251:08 pmPRNNet Asset Value(s)
17th Nov 20251:51 pmPRNNet Asset Value(s)
14th Nov 20255:17 pmPRNTransaction in Own Shares
14th Nov 202512:00 pmPRNNet Asset Value(s)
13th Nov 20252:18 pmPRNNet Asset Value(s)
12th Nov 20254:37 pmPRNResult of General Meeting
12th Nov 20251:10 pmPRNNet Asset Value(s)
12th Nov 202511:13 amPRNMonthly Fact Sheet as at 31 October 2025
11th Nov 20251:22 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.